Activated Akt-1 in specific cell populations during multi-stage skin carcinogenesis

Anticancer Research

Volumn 24, Issue 5 A, 2004, Pages 2773-2781

  Affara, Nesrine I ^a   Schanbacher, Brandon L ^b   Mihm, Michael J ^b   Cook, Angela C ^b   Pei, Ping ^c   Mallery, Susan R ^c,d   Trempus, Carol S ^e   Bauer, John A ^b   Robertson, Fredika M ^a,d  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Akt 1; Cell survival; Epidermal keratinocytes; Image analysis; Inositidylphosphate 3 kinase; IP3 K; Mast cells; Multi stage skin carcinogenesis; Papilloma; Protein kinase B

Indexed keywords

DIMETHYLBENZ[A]ANTHRACENE; PROTEIN KINASE B; PROTEIN KINASE B 1; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CELL COUNT; CELL DIFFERENTIATION; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EPIDERMIS CELL; FEMALE; GENE ACTIVATION; MAST CELL; MICROENVIRONMENT; MOUSE; NEUTROPHIL; NONHUMAN; PAPILLOMA; PRIORITY JOURNAL; SKIN CANCER; SKIN CARCINOGENESIS; SKIN TUMOR;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ACETONE; ANIMALS; BLOTTING, WESTERN; CARCINOGENS; ENZYME ACTIVATION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; MAST CELLS; MICE; MICE, INBRED SENCAR; NEUTROPHILS; PAPILLOMA; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SKIN; SKIN NEOPLASMS; STROMAL CELLS; TETRADECANOYLPHORBOL ACETATE;

EID: 6444226074     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Balmain A, Brown K, Akhurst RJ and Fee FM: Molecular analysis of chemical carcinogenesis in the skin. Br J Cancer Suppl 9: 72-5, 1988.
2. Balmain ARamsden M, Bowden GT and Smith J: Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas. Nature 307: 658-60, 1984.
3. Binder RL, Gallagher PM, Johnson GR, Stockman SL, Smith BJ, Sundberg JP and Conti CJ: Evidence that initiated keratinocytes clonally expand into multiple existing hair follicles during papilloma histogenesis in SENCAR mouse skin. Mol Carcinog 20: 151-8, 1997.
4. Martinez LA, Chen Y, Fischer SM and Conti CJ: Coordinated changes in cell cycle machinery occur during keratinocyte terminal differentiation. Oncogene 18: 397-406, 1999.
5. DiGiovanni J, Bol DK, Wilker E, Beltran L, Carbajal S, Moats S, Ramirez A, Jorcano J and Kiguchi K: Constitutive expression of insulin-like growth factor-1 in epidermal basal cells of transgenic mice leads to spontaneous tumor promotion. Cancer Res 60: 1561-70, 2000.
6. Segrelles C, Ruiz S, Perez P, Murga C, Santos M, Budunova IV, Martinez J, Larcher F, Slaga TJ, Gutkind JS, Jorcano JL and Paramio JM: Functional roles of Akt signaling in mouse skin tumorigenesis. Oncogene 21: 53-64, 2002.
7. Sun M, Wang G, Paciga JE, Feldman RI, Yuan ZQ, Ma XL, Shelley SA, Jove R, Tsichlis PN, Nicosia SV and Cheng JQ: AKT1/PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells. Am J Pathol 159: 431-7, 2001.
8. Peng XD, Xu PZ, Chen ML, Hahn-Windgassen A, Skeen J, Jacobs J, Sundararajan D, Chen WS, Crawford SE, Coleman KG and Hay N: Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev 17:1352-65, 2003.
9. Segrelles C, Ruiz S, Santos M, Martinez-Palacio J, Lara MF and Paramio JM: Akt mediates an angiogenic switch in transformed keratinocytes. Carcinogenesis 25: 1137-47, 2004.
10. Robertson FM, Ross MS, Tober KL, Long BW and Oberyszyn TM: Inhibition of pro-inflammatory cytokine gene expression and papilloma growth during murine multistage carcinogenesis by pentoxifylline. Carcinogenesis 17: 1719-28, 1996.
11. Mihm MJ, Coyle CM, Jing L and Bauer JA: Vascular peroxynitrite formation during organic nitrate tolerance. J Pharmacol Exp Ther 291: 194-8, 1999.
12. Coussens LM, Raymond WW, Bergers G, Laig-Webster M, Behrendtsen O, Werb Z, Caughey GH and Hanahan D: Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev 13: 1382-97, 1999.
13. Schueller E, Peutsch M, Bohacek LG and Gupta RK: A simplified toluidine blue stain for mast cells. Can J Med Technol 29: 137-8, 1967.
14. Mihm MJ, Coyle CM, Schanbacher BL, Weinstein DM and Bauer JA: Peroxynitrite induced nitration and inactivation of myofibrillar creatine kinase in experimental heart failure. Cardiovasc Res 49: 798-807, 2001.
15. Mihm MJ, Yu F, Weinstein DM, Reiser PJ and Bauer JA: Intracellular distribution of peroxynitrite during doxorubicin cardiomyopathy: evidence for selective impairment of myofibrillar creatine kinase. Br J Pharmacol 135: 581-8, 2002.
16. Poladia DP and Bauer JA: Early cell-specific changes in nitric oxide synthases, reactive nitrogen species formation and ubiquitinylation during diabetes-related bladder remodeling. Diabetes Metab Res Rev 19: 313-9, 2003.
17. Trush MA, Egner PA and Kensler TW: Myeloperoxidase as a biomarker of skin irritation and inflammation. Food Chem Toxicol 32: 143-7, 1994.
18. Leis H, Segrelles C, Ruiz S, Santos M and Paramio JM: Expression, localization and activity of glycogen synthase kinase 3beta during mouse skin tumorigenesis. Mol Carcinog 55: 180-5, 2002.
19. Stenback F, Peto R and Shubik P: Initiation and promotion at different ages and doses in 2200 mice. I. Methods and the apparent persistence of initiated cells. Br J Cancer 44: 1-14, 1981.
20. Ariza ME, Oberyszyn AS, Robertson FM and Williams MV: Mutagenic potential of peripheral blood leukocytes: in vivo exposure to the carcinogen 7,12-dimethylbenz[a]anthracene and the tumor promoter 12-O-tetradecanoylphorbol acetate followed by in vitro co-culture with AS52 cells. Cancer Lett 106: 9-16, 1996.
21. Sirak AA, Beavis AJ and Robertson FM: Enhanced hydroperoxide production by peripheral blood leukocytes following exposure of murine epidermis to 12-O-tetradecanoylphorbol-13-acetate. Carcinogenesis 12: 91-5, 1991.
22. Huang S, Van Arsdall M, Tedjarati S, McCarty M, Wu W, Langley R and Fidler IJ: Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. J Natl Cancer Inst 94: 1134-42, 2002.
23. Robertson FM, Beavis AJ, Oberyszyn TM, O'Connell SM, Dokidos A, Laskin DL, Laskin JD and Reiners JJ Jr: Production of hydrogen peroxide by murine epidermal keratinocytes following treatment with the tumor promoter 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 50: 6062-7, 1990.
24. Robertson FM, Long BW, Tober KL, Ross MS and Oberyszyn TM: Gene expression and cellular sources of inducible nitric oxide synthase during tumor promotion. Carcinogenesis 17: 2053-9, 1996.
25. Perchellet EM, Abney NL and Perchellet JP: Stimulation of hydroperoxide generation in mouse skins treated with tumor-promoting or carcinogenic agents in vivo and in vitro. Cancer Lett 42: 169-77, 1988.
26. Fischer SM, Cameron GS, Baldwin JK, Jasheway DW and Patrick KE: Reactive oxygen in the tumor promotion stage of skin carcinogenesis. Lipids 23: 592-7, 1988.
27. Oberyszyn TM, Sabourin CL, Bijur GN, Oberyszyn AS, Boros LG and Robertson FM: Interleukin-1 alpha gene expression and localization of interleukin-1 alpha protein during tumor promotion. Mol Carcinog 7: 238-48, 1993.
28. Robertson FM, Bijur GN, Oberyszyn AS, Pellegrini AE, Boros LG, Sabourin CL and Oberyszyn TM: Granulocyte-macrophage colony stimulating factor gene expression and function during tumor promotion. Carcinogenesis 75: 1017-29, 1994.
29. Wang X, McCullough KD, Franke TF and Holbrook NJ: Epidermal growth factor receptor-dependent Akt activation by oxidative stress enhances cell survival. J Biol Chem 275: 14624-31, 2000.
30. Huang C, Li J, Ding M, Leonard SS, Wang L, Castranova V, Vallyathan V and Shi X: UV Induces phosphorylation of protein kinase B (Akt) at Ser-473 and Thr-308 in mouse epidermal CI 41 cells through hydrogen peroxide. J Biol Chem 276: 40234-40, 2001.
31. Butts BD, Kwei KA, Bowden GT and Briehl MM: Elevated basal reactive oxygen species and phospho-Akt in murine keratinocytes resistant to ultraviolet B-induced apoptosis. Mol Carcinog 37: 149-57, 2003.
32. 2 or heat shock is mediated by phosphoinositide 3-kinase and not by mitogen-activated protein kinase-activated protein kinase-2. Biochem J 336: 241-6, 1998.
33. Klotz LO, Schieke SM, Sies H and Holbrook NJ: Peroxynitrite activates the phosphoinositide 3-kinase/Akt pathway in human skin primary fibroblasts. Biochem J 352 Pt 1: 219-25, 2000.
34. Potten CS and Booth C: Keratinocyte stem cells: a commentary. J Invest Dermatol 119: 888-99, 2002.
35. Morris RJ: Keratinocyte stem cells: targets for cutaneous carcinogens. J Clin Invest 106: 3-8, 2000.
36. Morris RJ, Liu Y, Marles L, Yang Z, Trempus C, Li S, Lin JS, Sawicki JA and Cotsarelis G: Capturing and profiling adult hair follicle stem cells. Nat Biotechnol 22: 411-7, 2004.
37. Morris RJ, Tryson KA and Wu KQ: Evidence that the epidermal targets of carcinogen action are found in the interfollicular epidermis of infundibulum as well as in the hair follicles. Cancer Res 60: 226-9, 2000.